Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ovarian cancer early detection"'
Autor:
David Stockheim, Eitan Friedman, Ariella Jakobson-Setton, Tamar Perri, Oranit Zadok, Jacob Korach, Nissim Arbib, Sarit Aviel-Ronen, Shunit Armon, Keren Bahar-Shany, Tamar Geiger, Keren Levanon, Limor Helpman, Yfat Kadan, Mario E. Beiner, Michal Harel, Hadar Brand, Ram Eitan, Anna Blecher, Georgina D. Barnabas, Stav Sapoznik, Guy Katz, Omer Weitzner, Benny Brandt
Publikováno v:
Mol Cell Proteomics
High-grade ovarian cancer (HGOC) is the leading cause of mortality from gynecological malignancies, because of diagnosis at a metastatic stage. Current screening options fail to improve mortality because of the absence of early-stage-specific biomark
Publikováno v:
Clin Cancer Res
PURPOSE: The current paradigm in the development of high-grade serous ovarian carcinoma (HGSC) proposes that the majority of HGSCs arise from precursor serous tubal intraepithelial carcinoma (STIC) lesions of the fallopian tube. Here we survey genome
Autor:
Karen L. Belkic, Miri Cohen, Marcela Marquez, Miriam Mints, Brigitte Wilczek, Anne H. Berman, Enrique Castellanos, Martha Castellanos
Publikováno v:
Oncology Reviews, Vol 4, Iss 4 (2011)
Low breast cancer screening rates are often found among ethnic minority groups and those born outside the host country. This is of particular concern for high-risk groups, who should benefit from ongoing trials aimed at optimizing screening strategie
Externí odkaz:
https://doaj.org/article/6866f76a43b14ebb8cf73494ce7b8061
Autor:
Petra H.M. Peeters, Anika Hüsing, Marina Kvaskoff, Hidemi S. Yamamoto, Eva Lundin, Carlotta Sacerdote, Elio Riboli, Renée T. Fortner, Louise Hansen, Elisabete Weiderpass, Heiner Boeing, Daniel W. Cramer, J. Ramón Quirós, Gianluca Severi, Kathryn L. Terry, Amalia Mattiello, Eric J. Duell, Rosario Tumino, Eva Ardanaz, Helena Schock, Titilayo Fashemi, Björn Nodin, Ruth C. Travis, Anne Tjønneland, Kim Overvad, Annika Idahl, Laure Dossus, Carmen Navarro, H B As Bueno-de-Mesquita, Carlo La Vecchia, Marie-Christine Boutron-Ruault, Allison F. Vitonis, Nerea Larrañaga, María José Sánchez, Domenico Palli, Marc J. Gunter, Karin Jirström, Antonia Trichopoulou, Charlotte Le Cornet, Mattias Johansson, Raina N. Fichorova, Kay-Tee Khaw, N. Charlotte Onland-Moret, Theron Johnson, Melissa A. Merritt, Sabina Sieri, Eleni-Maria Papatesta, Rudolf Kaaks
Publikováno v:
International Journal of Cancer. 142:1355-1360
CA125 is the best ovarian cancer early detection marker to date; however, sensitivity is limited and complementary markers are required to improve discrimination between ovarian cancer cases and no ...
Autor:
Lavinia Margarit, Alexandra T. Gourlan, R.S. Conlan, P. Telouk, Lewis Francis, Laurent Charlet, Kerryn Lutchman-Singh, B. Toubhans, Deyarina Gonzalez
Publikováno v:
Journal of Trace Elements in Medicine and Biology. 62:126611
Background Ovarian cancer diagnosis is currently based on imaging and circulating CA-125 concentrations with well-known limits to sensitivity and specificity. New biomarkers are required to complement CA-125 testing to increase effectiveness. Increas
Publikováno v:
Polish Journal of Public Health. 125:24-28
I Chair and Department of Gynecological Oncology and Gynecology is a specialist research center providing help in diagnostics and treatment of gynecological malignancies. The research work is focused on the processes of angiogenesis and lymphangiogen
Publikováno v:
Journal of Visualized Experiments.
Currently, it is widely accepted that the vast majority of ovarian high-grade serous carcinoma (HGSC) originate from the fallopian tube. However, due to the lack of markers or tools for the ovarian cancer identification, the early detection of HGSC r
Publikováno v:
Gynecologic oncology. 147(2)
Objectives Tumor-associated autoantibodies (AAbs), produced as an immune response to tumor-associated antigens (TAAs), are a novel pathway of early detection markers. Methods We conducted a systematic review on AAbs and ovarian cancer to summarize th
Autor:
Garnet L. Anderson, Alicia Sato, Nancy B. Kiviat, Kathy O'Briant, Nicole Urban, Meghan Crawford, Charles W. Drescher, Nathalie Scholler
Publikováno v:
Clinical Cancer Research. 12:2117-2124
Purpose: Efforts to validate ovarian cancer early detection biomarkers with immunoassays are challenged by the limited specimen volumes available. We sought to develop a specimen-efficient assay to measure CA125 in serum, assess its reproducibility,
Publikováno v:
Gynecologic Oncology. 141:57-58